| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
Aetna
| Professional | $3,920.00 | $3,920.00 | $3,920.00 | |
BCBS
| Professional | $4,900.00 | $4,900.00 | $4,900.00 | |
United
| Professional | $1,646.40 | $1,646.40 | $3,920.00 |
Oncology (pan-cancer), analysis of minimal residual disease (MRD) from plasma, with assays personalized to each patient based on prior next-generation sequencing of the patient's tumor and germline DNA, reported as absence or presence of MRD, with disease-burden correlation, if appropriate
| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
Aetna
| Professional | $3,920.00 | $3,920.00 | $3,920.00 | |
BCBS
| Professional | $4,900.00 | $4,900.00 | $4,900.00 | |
United
| Professional | $1,646.40 | $1,646.40 | $3,920.00 |